HYPOTHESIS AND THEORY
Accepted on 26 Feb 2025
A syringeable immunotherapeutic hydrogel enhances T cell immunity via in-situ activation of STING pathway for advanced breast cancer postoperative therapy
doi 10.3389/fimmu.2025.1523436
2,513
Total downloads
8,449
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
HYPOTHESIS AND THEORY
Accepted on 26 Feb 2025
ORIGINAL RESEARCH
Accepted on 25 Feb 2025
ORIGINAL RESEARCH
Accepted on 24 Feb 2025
ORIGINAL RESEARCH
Published on 09 Oct 2024
REVIEW
Published on 27 Sep 2024
REVIEW
Published on 30 Jul 2024
ORIGINAL RESEARCH
Published on 26 Jul 2024
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: